These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 37145885)

  • 1. Current status of Guillain-Barré syndrome (GBS) in China: a 10-year comprehensive overview.
    Song Y; Zheng X; Fang Y; Liu S; Liu K; Zhu J; Wu X
    Rev Neurosci; 2023 Dec; 34(8):869-897. PubMed ID: 37145885
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Guillain-Barré Syndrome in Mexico: An Updated Review Amid the Coronavirus Disease 2019 ERA.
    Galnares-Olalde JA; López-Hernández JC; García-Grimshaw M; Valdés-Ferrer SI; Briseño-Godínez ME; de-Sarachaga AJ; Alegría-Loyola MA; Bazán-Rodriguez A; Martínez-Jiménez E; Vargas-Cañas ES
    Rev Invest Clin; 2022 May; 74(3):121-130. PubMed ID: 35345064
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Is there a causal nexus between COVID-19 infection, COVID-19 vaccination, and Guillain-Barré syndrome?
    Zheng X; Fang Y; Song Y; Liu S; Liu K; Zhu J; Wu X
    Eur J Med Res; 2023 Feb; 28(1):98. PubMed ID: 36841799
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SARS-CoV-2 and Guillain-Barré Syndrome: Lessons from Viral Infections.
    Meidaninikjeh S; Sabouni N; Taheri M; Borjkhani M; Bengar S; Majidi Zolbanin N; Khalili A; Jafari R
    Viral Immunol; 2022 Jul; 35(6):404-417. PubMed ID: 35766944
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intravenous immunoglobulin for Guillain-Barré syndrome.
    Hughes RA; Swan AV; van Doorn PA
    Cochrane Database Syst Rev; 2014 Sep; 2014(9):CD002063. PubMed ID: 25238327
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Axonal Guillain-Barre syndrome associated with SARS-CoV-2 infection in a child.
    Akçay N; Menentoğlu ME; Bektaş G; Şevketoğlu E
    J Med Virol; 2021 Sep; 93(9):5599-5602. PubMed ID: 33851741
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epidemiological and cohort study finds no association between COVID-19 and Guillain-Barré syndrome.
    Keddie S; Pakpoor J; Mousele C; Pipis M; Machado PM; Foster M; Record CJ; Keh RYS; Fehmi J; Paterson RW; Bharambe V; Clayton LM; Allen C; Price O; Wall J; Kiss-Csenki A; Rathnasabapathi DP; Geraldes R; Yermakova T; King-Robson J; Zosmer M; Rajakulendran S; Sumaria S; Farmer SF; Nortley R; Marshall CR; Newman EJ; Nirmalananthan N; Kumar G; Pinto AA; Holt J; Lavin TM; Brennan KM; Zandi MS; Jayaseelan DL; Pritchard J; Hadden RDM; Manji H; Willison HJ; Rinaldi S; Carr AS; Lunn MP
    Brain; 2021 Mar; 144(2):682-693. PubMed ID: 33313649
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Guillain-Barré syndrome after SARS-CoV-2 infection in an international prospective cohort study.
    Luijten LWG; Leonhard SE; van der Eijk AA; Doets AY; Appeltshauser L; Arends S; Attarian S; Benedetti L; Briani C; Casasnovas C; Castellani F; Dardiotis E; Echaniz-Laguna A; Garssen MPJ; Harbo T; Huizinga R; Humm AM; Jellema K; van der Kooi AJ; Kuitwaard K; Kuntzer T; Kusunoki S; Lascano AM; Martinez-Hernandez E; Rinaldi S; Samijn JPA; Scheidegger O; Tsouni P; Vicino A; Visser LH; Walgaard C; Wang Y; Wirtz PW; Ripellino P; Jacobs BC;
    Brain; 2021 Dec; 144(11):3392-3404. PubMed ID: 34553216
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical features, pathogenesis, and treatment of Guillain-Barré syndrome.
    van Doorn PA; Ruts L; Jacobs BC
    Lancet Neurol; 2008 Oct; 7(10):939-50. PubMed ID: 18848313
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A 44-Year-Old Hispanic Man with Loss of Taste and Bilateral Facial Weakness Diagnosed with Guillain-Barré Syndrome and Bell's Palsy Associated with SARS-CoV-2 Infection Treated with Intravenous Immunoglobulin.
    Khaja M; Gomez GPR; Santana Y; Hernandez N; Haider A; Lara JLP; Elkin R
    Am J Case Rep; 2020 Oct; 21():e927956. PubMed ID: 33128540
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Guillain-Barré syndrome in an era of global infections and 21st century vaccination.
    Lunn MP
    Curr Opin Neurol; 2022 Oct; 35(5):571-578. PubMed ID: 36069416
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Guillain-Barré syndrome spectrum associated with COVID-19: an up-to-date systematic review of 73 cases.
    Abu-Rumeileh S; Abdelhak A; Foschi M; Tumani H; Otto M
    J Neurol; 2021 Apr; 268(4):1133-1170. PubMed ID: 32840686
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Guillain-Barré syndrome: clinical profile and management.
    Sudulagunta SR; Sodalagunta MB; Sepehrar M; Khorram H; Bangalore Raja SK; Kothandapani S; Noroozpour Z; Aheta Sham M; Prasad N; Sunny SP; Mohammed MD; Gangadharappa R; Nidsale Sudarshan R
    Ger Med Sci; 2015; 13():Doc16. PubMed ID: 26421004
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Guillain-Barré syndrome in patients with SARS-CoV-2 infection. Report of three cases.
    Cea G; Romero C; Aguilar S; Salinas R
    Rev Med Chil; 2021 Dec; 149(12):1812-1816. PubMed ID: 35735350
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Guillain-Barré syndrome (GBS).
    Pithadia AB; Kakadia N
    Pharmacol Rep; 2010; 62(2):220-32. PubMed ID: 20508277
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Guillain-Barré syndrome and COVID-19: A 1-year observational multicenter study.
    Filosto M; Cotti Piccinelli S; Gazzina S; Foresti C; Frigeni B; Servalli MC; Sessa M; Cosentino G; Marchioni E; Ravaglia S; Briani C; Castellani F; Zara G; Bianchi F; Del Carro U; Fazio R; Filippi M; Magni E; Natalini G; Palmerini F; Perotti AM; Bellomo A; Osio M; Nascimbene C; Carpo M; Rasera A; Squintani G; Doneddu PE; Bertasi V; Cotelli MS; Bertolasi L; Fabrizi GM; Ferrari S; Ranieri F; Caprioli F; Grappa E; Manganotti P; Bellavita G; Furlanis G; De Maria G; Leggio U; Poli L; Rasulo F; Latronico N; Nobile-Orazio E; Beghi E; Padovani A; Uncini A
    Eur J Neurol; 2022 Nov; 29(11):3358-3367. PubMed ID: 35837806
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Case of Guillain-Barré Syndrome Associated With COVID-19.
    Rajdev K; Victor N; Buckholtz ES; Hariharan P; Saeed MA; Hershberger DM; Bista S
    J Investig Med High Impact Case Rep; 2020; 8():2324709620961198. PubMed ID: 32981333
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical features and outcome of Guillain-Barre syndrome in Saudi Arabia: a multicenter, retrospective study.
    Alanazy MH; Bakry SS; Alqahtani A; AlAkeel NS; Alazwary N; Osman AM; Mustafa RA; Al-Harbi TM; Abdulmana SO; Amper AC; Aldughaythir Y; Ali AS; Makkawi S; Maglan A; Alamoudi L; Alsulaiman F; Alabdali M; AlShareef AA; Abuzinadah AR; Bamaga AK
    BMC Neurol; 2021 Jul; 21(1):275. PubMed ID: 34253174
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Guillain-Barré syndrome associated with SARS-CoV-2 infection: A systematic review and individual participant data meta-analysis.
    Hasan I; Saif-Ur-Rahman KM; Hayat S; Papri N; Jahan I; Azam R; Ara G; Islam Z
    J Peripher Nerv Syst; 2020 Dec; 25(4):335-343. PubMed ID: 33112450
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Guillain-Barré syndrome: clinical features, treatment choices and outcomes in an Australian cohort.
    Barnes SL; Herkes GK
    Intern Med J; 2020 Dec; 50(12):1500-1504. PubMed ID: 31760675
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.